Dexamethasone, methylprednisolone, hydrocortisone and prednisolone all sit on the WHO Model List of Essential Medicines, which national authorities adapt into their own essential medicines lists. Demand for this category is concentrated in public tender and hospital formulary procurement.
47 of these 171 lines are pressurised metered-dose inhalers and 30 are nasal sprays, both requiring fill capability separate from standard oral and sterile lines.
Range depth
23 formoterol and 16 fluticasone presentations.
6 tiotropium presentations.
30 aqueous nasal presentations.
24 montelukast presentations.
We establish what is already registered in your market, who supplies it today, and where demand is going unmet.
We set your current range against the portfolio and separate genuine gaps from lines you already stock.
You get the molecules in filing order, which of them need a dossier built for your authority, and which fall outside the range.
We compile the dossier in CTD format for your authority and supply the COPP and plant-level WHO-GMP and PIC/S certificates behind it.
We analyse your market and set your existing range against the portfolio, then return the molecules worth filing in priority order with the documentation route for each.